United States · 
Who invested in DermBiont?
DermBiont's investors include Viking Global, Toba Capital, Joyance Partners and Zola Global Investors.
2020202120222023
$8.0MSeries A$35MSeries B
United States · Series B startup
Who invested in DermBiont
Funding summaryUpdated 26 Oct 2026
$43Mraised across 2 rounds since 2019, from 2 sources
$8.0MSeries A$35MSeries B
- Latest round
- Series B, $35MOct 2023
- Step-upi
- 4.4×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $8.0M Jun 2019
- Biggest round
- $35M Series B · Oct 2023
- Between rounds
- 4.3 years from the last two
The rounds
- Oct 2023Series B$35M1 new1 returning
Source recordedSEC filing: $8.1M sold, first sale Oct 2023
- Jun 2019Series A$8.0M3 new
Reported by FinSMEsSEC filing: $8.8M sold, first sale May 2019
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 3 firms list DermBiont as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about DermBiont
How much has DermBiont raised?
DermBiont has raised $43M across 2 rounds since 2019.
When did DermBiont last raise?
DermBiont's most recent round was a Series B of $35M in Oct 2023.
What was DermBiont's biggest round?
Its most recent round, $35M in Oct 2023, is also its largest on record.
Who backed DermBiont first?
DermBiont's first round on record, in Jun 2019, was backed by Viking Global, Toba Capital and Zola Global Investors.
What stage is DermBiont at?
DermBiont's latest named round is a Series B, in Oct 2023.
Where is DermBiont based?
DermBiont is based in the United States.
Companies like DermBiont
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.